British national, living in Switzerland since 2009. Married with three children.
15 years in private client finance; first as an independent financial advisor – Swiss market, followed by private banker – Southern Africa market with Coutts & Co., the Royal Bank of Canada and then Banque SYZ.
I went independent in 2017 with the backing of several HNW families. Founded GPCS Sarl in 2018, a consulting firm and became a Partner of ISGAM AG in 2020.
My experience includes operational and asset succession planning for private clients and companies, as well as compliance and risk management for the Swiss, South African, UK and US markets.
Louis is a financial planner and relationship manager at ISGAM AG. He caters for an international clientele across Switzerland, the UK, The Netherlands and The Middle East. Louis is a younger member of the ISGAM team and has been, and continues to be, deeply involved in the firm’s succession planning. Louis is an associate member of the Chartered Institute for Securities & Investment (CISI), holds a Bachelor degree in the arts from the Royal Conservatoire of The Hague and will soon hold a second combined degree in psychology, philosophy and economics. In his spare time, Louis enjoys long distance swimming, reading classical literature, charity work and (very) amateur chess.
Vivek Mahadevan joined Siemens Energy in 2008 and has a background in product engineering, specialising in the mechanical design and structural integrity of steam turbine and gas turbine components (rotors and casings).
For the last few years, his role as an engineering technical lead has focussed on developing solutions globally to enable stability of the electrical grid, by converting existing gas and steam turbo-generator power plants.
He has worked on the overall integrated plant solution from initial development to final implementation, including the rotating mechanical shaft line, balance of plant, auxiliary systems, civil interfaces, electrical integration, and interface with the grid.
Harvard educated (BA Biology, JD, MPH), exceptionally well-rounded, and award winning life sciences venture capitalist with operating, entrepreneurial, legal (IP & FDA) and pharmaceutical management consulting experience and a science background. An entrepreneurial journey as a female founder and CEO “growing up” on the tech side (digital health) makes me a unique biotech investor with a founder friendly bent and a lean startup mindset.
20 years of biopharma and healthcare industry experience. Board Director or Observer of 8 biotechs with 3 exits in 2 years. Led/Shepard 3 large pharma deals (AZ, Pfizer, Takeda).
Skilled in life sciences and healthcare venture investing, board governance, BD, strategy, management, fundraising/startup operations, IP law, Food & Drug regulation, tech transfer, and cross-border international business with Asia.
Christina has over 20 years experience in Pharma holding various positions within Clinical Operations, Medical Affairs, Project Management, and the last 5 years in Global Clinical Supply Chain.
Throughout the course of her career, she has provided support across all phases of Sponsor Clinical Studies at Incyte, GSK, Bristol Myers Squibb, and Gilead Sciences, as well as management of Expanded Access Programs and Investigator initiated trials.
She currently holds the position of Director, Global Clinical Supply Chain at Incyte, with a focus in patient-centric forecasting, strategic planning, and distribution of drug supply for Incyte’s portfolio.
